Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 24956

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
β-endorphin (1-26) is a neuropeptide found in rat hippocampus, brain stem, and pituitary.1 It is also present in the human hypothalamus, where it comprises approximately 13.1% of total β-endorphin.2 β-endorphin (1-26) is an opioid receptor agonist that inhibits potassium-induced norepinephrine (NE) release in rat cortical slices (IC50 = 2.5 nM).3 It reverses inhibition of potassium-induced NE release from rat cortical slices induced by the opioid antagonists naloxone (Item No. 15594), CTOP, norbinaltorphimine (nor-BNI), and naltrindole (Item No. 9000705; pA2s = 7.59-8.63). In vivo, β-endorphin (1-26) (10 μg, i.c.v.) induces transient bradycardia in anesthetized rats.4 Intracerebroventricular administration of β-endorphin (1-26) increases the latency to tail withdrawal in response to thermal stimulation in mice with a median antinociceptive dose (AD50) of 1.57 μg per animal.5
WARNING This product is not for human or veterinary use.
1. β-
2. The posttranslational processing of β-
3. Inhibition of norepinephrine release from rat cortex slices by opioids: Differences among agonists in sensitivities to antagonists suggest receptor heterogeneity. J. Pharmacol. Exp. Ther. 267(3), 1153-1160 (1993).
4. Effects of dynorphin A(1-
5. β-